Clinical Trial Update: Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in China [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluates the safety and efficacy of Benefix in Hemophilia B patients in usual care settings in China. The study's results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• BeneFIX (recombinant coagulation factor IX concentrate)

Snippet

Sponsor: Pfizer | Conditions: HEMOPHILIA B | Phase 4 | Status: COMPLETED | Results posted: 2017-05-04